Besides, TH5487 enhances the sensitivity to the PARP inhibitor olaparib, especially in the context of BRCA1 deficiency, reflecting an additive interaction. The gene discussed is BRCA1; the disease is hyperinsulinemic hypoglycemia, familial, 4.